CTOs on the Move

Uroplasty

www.uroplasty.com

 
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Antelope Valley Hospital

Antelope Valley Hospital, the only full-service, acute-care hospital in the Antelope Valley, has been delivering exceptional care to the community for more than 60 years. It offers the regions only trauma center, pediatric unit, NICU, inpatient mental health care, labor and delivery, Accredited Chest Pain Center/STEMI Receiving Center, Advanced Primary Stroke Center and Comprehensive Community Cancer Center.

Diteba Research Laboratories

Diteba Research Laboratories is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SmartPractice

At SmartPractice, our mission is to improve world health by improving health care practices. Our focus is on helping you create practice conditions that allow you to interact with more patients.

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

East Central Health

East Central Health is a Tofield, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.